Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature Communications (14)
Nature (11)
British Journal of Cancer (8)
Oncogene (6)
Nature Genetics (6)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (61)
Amendments and Corrections (6)
Reviews (2)

Subject Check one or more subjects to show results from those subjects only.

Biomarkers
Biotechnology
Cancer
Cardiology
Cell biology
Chemical biology
Diseases
Drug discovery
Ecology
Genetics
Immunology
Medical research
Microbiology
Molecular biology
Neurology
Neuroscience
Oncology
Pathogenesis
Plant sciences
Signs and symptoms

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 51–69 of 69 results

Advanced filters: Author: Murray Norris Clear advanced filters

Too many targets, not enough patients: rethinking neuroblastoma clinical trials

This Perspective provides an update on targeted therapy development for neuroblastoma and proposes that clinical trial design needs to be rethought in order to provide rigorous, evidence-based assessment of these new therapies in this rare and often deadly paediatric tumour.

Jamie I. Fletcher
David S. Ziegler
Murray D. Norris
Reviews09 Apr 2018
Nature Reviews Cancer

Volume: 18, P: 389-400
Combination efficacy of ruxolitinib with standard-of-care drugs in CRLF2-rearranged Ph-like acute lymphoblastic leukemia

Julia W. Bӧhm
Keith C. S. Sia
Richard B. Lock
Research24 Apr 2021
Leukemia

Volume: 35, P: 3101-3112
Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin

Mawar Karsa
Angelika Kosciolek
Klaartje Somers
Research09 Apr 2021
British Journal of Cancer

Volume: 125, P: 55-64
β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma

E Pasquier
J Street
M Kavallaris
ResearchOpen Access21 May 2013
British Journal of Cancer

Volume: 108, P: 2485-2494
Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma

Vinod Vijay Subhash
Libby Huang
Toby N. Trahair
ResearchOpen Access01 Sept 2021
British Journal of Cancer

Volume: 126, P: 482-491
A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma

Belamy B. Cheung
Ane Kleynhans
Glenn M. Marshall
ResearchOpen Access03 Mar 2021
Oncogene

Volume: 40, P: 2367-2381
JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis

Jennifer R. Lynch
Basit Salik
Jenny Y. Wang
Research08 Jan 2019
Leukemia

Volume: 33, P: 1400-1410
OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis

Lioubov Korotchkina
Denis Kazyulkin
Andrei V. Gudkov
ResearchOpen Access02 Jan 2020
Leukemia

Volume: 34, P: 1828-1839
Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy

Alvin Kamili
Andrew J. Gifford
Jamie I. Fletcher
ResearchOpen Access10 Jan 2020
British Journal of Cancer

Volume: 122, P: 680-691
Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemia

Klaartje Somers
Kathryn Evans
Michelle J. Henderson
Research17 Dec 2019
Leukemia

Volume: 34, P: 1524-1539
Transcriptome profiling of caspase-2 deficient EμMyc and Th-MYCN mouse tumors identifies distinct putative roles for caspase-2 in neuronal differentiation and immune signaling

Loretta Dorstyn
Emily Hackett-Jones
Sharad Kumar
ResearchOpen Access22 Jan 2019
Cell Death & Disease

Volume: 10, P: 1-16
A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction

Klaartje Somers
Victoria W. Wen
Michelle J. Henderson
ResearchOpen Access22 Jan 2019
Oncogene

Volume: 38, P: 3824-3842
Publisher Correction: Shared heritability and functional enrichment across six solid cancers

Xia Jiang
Hilary K. Finucane
Sara Lindström
Amendments and CorrectionsOpen Access23 Sept 2019
Nature Communications

Volume: 10, P: 1-8
Spatial epidemiological patterns suggest mechanisms of land-sea transmission for Sarcocystis neurona in a coastal marine mammal

Tristan L. Burgess
M. Tim Tinker
Christine K. Johnson
ResearchOpen Access28 Feb 2020
Scientific Reports

Volume: 10, P: 1-9
Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera

Kelly J. Roper
Jordan Thomas
Georgios Pollakis
ResearchOpen Access11 Sept 2023
Scientific Reports

Volume: 13, P: 1-12
Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array

Edward J Saunders
Tokhir Dadaev
Zsofia Kote-Jarai
ResearchOpen Access10 Mar 2016
British Journal of Cancer

Volume: 114, P: 945-952
Framework for development of physician competencies in genomic medicine: report of the Competencies Working Group of the Inter-Society Coordinating Committee for Physician Education in Genomics

Bruce R. Korf
Anna B. Berry
Laura L. Rodriguez
Research24 Apr 2014
Genetics in Medicine

Volume: 16, P: 804-809
Intratumoral delivery of shRNA targeting cyclin D1 attenuates pancreatic cancer growth

S J Deharvengt
J R Gunn
M Korc
Research23 Oct 2009
Cancer Gene Therapy

Volume: 17, P: 325-333
A Kras^G12D-driven genetic mouse model of pancreatic cancer requires glypican-1 for efficient proliferation and angiogenesis

C A Whipple
A L Young
M Korc
Research26 Sept 2011
Oncogene

Volume: 31, P: 2535-2544

Previous page
page 1
page 2
Next page

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

Search

Too many targets, not enough patients: rethinking neuroblastoma clinical trials

Combination efficacy of ruxolitinib with standard-of-care drugs in CRLF2-rearranged Ph-like acute lymphoblastic leukemia

Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin

β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma

Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma

A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma

JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis

OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis

Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy

Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemia

Transcriptome profiling of caspase-2 deficient EμMyc and Th-MYCN mouse tumors identifies distinct putative roles for caspase-2 in neuronal differentiation and immune signaling

A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction

Publisher Correction: Shared heritability and functional enrichment across six solid cancers

Spatial epidemiological patterns suggest mechanisms of land-sea transmission for Sarcocystis neurona in a coastal marine mammal

Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array

Framework for development of physician competencies in genomic medicine: report of the Competencies Working Group of the Inter-Society Coordinating Committee for Physician Education in Genomics

Intratumoral delivery of shRNA targeting cyclin D1 attenuates pancreatic cancer growth

A Kras^G12D-driven genetic mouse model of pancreatic cancer requires glypican-1 for efficient proliferation and angiogenesis

Search

Quick links